125 related articles for article (PubMed ID: 23461212)
1. [Autopsy case of light chain deposition disease presented by nephrotic syndrome].
Suzuki S; Yokota S; Masuyama T; Ogihara H; Ohishi M; Katayama N; Koizumi H; Namiki M
Nihon Jinzo Gakkai Shi; 2013; 55(1):63-70. PubMed ID: 23461212
[TBL] [Abstract][Full Text] [Related]
2. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
3. Light chain deposition disease without detectable light chains in serum or urine. Report of a case and review of the literature.
van Ingen G; van Bronswijk H; Meijer CJ; Stel HV
Neth J Med; 1991 Oct; 39(3-4):142-7. PubMed ID: 1791875
[TBL] [Abstract][Full Text] [Related]
4. Light-chain deposition disease of the kidney: a case report.
Darouich S; Goucha R; Jaafoura MH; Zekri S; Kheder A; Maiz HB
Ultrastruct Pathol; 2012 Apr; 36(2):134-8. PubMed ID: 22471437
[TBL] [Abstract][Full Text] [Related]
5. Resolution of mesangial light chain deposits 3 years after high-dose melphalan with autologous peripheral blood stem cell transplantation.
Harada K; Akai Y; Sakan H; Yamaguchi Y; Nakatani K; Iwano M; Saito Y
Clin Nephrol; 2010 Nov; 74(5):384-8. PubMed ID: 20979947
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of nephrotic syndrome induced by lambda light chain deposition disease using lenalidomide: A case report and review of the literature
.
Mima A; Nagahara D; Tansho K
Clin Nephrol; 2018 Jun; 89(6):461-468. PubMed ID: 29393843
[TBL] [Abstract][Full Text] [Related]
7. Two types of glomerular lesion in non-amyloid immunoglobulin deposition disease: a case report of IgD-lambda myeloma.
Kubo Y; Morita T; Koda Y; Hirasawa Y
Clin Nephrol; 1990 Jun; 33(6):259-63. PubMed ID: 2115826
[TBL] [Abstract][Full Text] [Related]
8. A patient with multiple myeloma, amyloidosis and light-chain deposition disease in kidneys with a long survival.
Christou L; Hatzimichael EC; Sotsiou-Candila F; Siamopoulos K; Bourantas KL
Acta Haematol; 1999; 101(4):202-5. PubMed ID: 10436302
[TBL] [Abstract][Full Text] [Related]
9. Light-Chain Deposition Disease Successfully Treated with Bortezomib in an Elderly Patient: A Case Report and Review of the Literature.
Wada Y; Iyoda M; Saito T; Arai-Nunota N; Iseri K; Tomita E; Ikeda M; Yamaguchi Y; Shibata T
Intern Med; 2015; 54(22):2893-8. PubMed ID: 26568005
[TBL] [Abstract][Full Text] [Related]
10. [A case of aggressive multiple myeloma].
Oda Y; Ooi S; Endoh A; Urushidani Y; Nakamura R; Adachi K
Gan To Kagaku Ryoho; 2011 Mar; 38(3):489-92. PubMed ID: 21403462
[TBL] [Abstract][Full Text] [Related]
11. Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report.
Kaposztas Z; Kahan BD; Katz SM; Van Buren CT; Cherem L
Transplant Proc; 2009 Dec; 41(10):4407-10. PubMed ID: 20005409
[TBL] [Abstract][Full Text] [Related]
12. Morphologic heterogeneity of renal light-chain deposition disease.
Gokden N; Barlogie B; Liapis H
Ultrastruct Pathol; 2008; 32(1):17-24. PubMed ID: 18300034
[TBL] [Abstract][Full Text] [Related]
13. [Deposition of light chains in various organs; light chain deposition disease].
van Klaveren RJ; Holdrinet RS; Assmann KJ
Ned Tijdschr Geneeskd; 1989 May; 133(18):943-6. PubMed ID: 2498673
[TBL] [Abstract][Full Text] [Related]
14. Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation.
Petrakis I; Stylianou K; Mavroeidi V; Vardaki E; Stratigis S; Stratakis S; Xylouri I; Perakis C; Petraki C; Nakopoulou L; Daphnis E
Nephrol Dial Transplant; 2010 Jun; 25(6):2020-3. PubMed ID: 20133281
[TBL] [Abstract][Full Text] [Related]
15. Light chain nephropathy: histological and clinical aspects in 15 cases.
Confalonieri R; Barbiano di Belgiojoso G; Banfi G; Ferrario F; Bertani T; Pozzi C; Casanova S; Lupo A; De Ferrari G; Minetti L
Nephrol Dial Transplant; 1988; 3(2):150-6. PubMed ID: 3140081
[TBL] [Abstract][Full Text] [Related]
16. [Light chain deposition disease. Experience in our environment].
Martín Herrera C; Suñer Poblet M; Cabrera R; Díaz Pedrero M; Fernández Alonso J
Nefrologia; 2008; 28(5):539-42. PubMed ID: 18816213
[TBL] [Abstract][Full Text] [Related]
17. Association light chain deposition disease (LCDD) and amyloidosis. One case.
Hofmann-Guilaine C; Nochy D; Jacquot C; Tricottet V; Bariety J; Camilleri JP
Pathol Res Pract; 1985 Aug; 180(2):214-9. PubMed ID: 3932985
[TBL] [Abstract][Full Text] [Related]
18. [More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)].
Adam Z; Nedbálková M; Krejcí M; Pour L; Husek K; Veselý K; Cermáková Z; Krivanová A; Mayer J; Hájek R
Vnitr Lek; 2010 Mar; 56(3):240-6. PubMed ID: 20394211
[TBL] [Abstract][Full Text] [Related]
19. A concurrence of light and heavy chain deposition disease and diabetic nephropathy.
Satirapoj B; Paueksakon P
J Med Assoc Thai; 2007 Oct; 90(10):2204-8. PubMed ID: 18041443
[TBL] [Abstract][Full Text] [Related]
20. [Serum free light-chain assay for nonsecretory multiple myeloma with light chain cast nephropathy and light chain deposition disease].
Honma R; Fukase S; Suzuki M; Omoto E
Rinsho Ketsueki; 2010 Apr; 51(4):270-4. PubMed ID: 20467224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
